{"id":385979,"date":"2022-04-21T00:00:00","date_gmt":"2022-04-21T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47037286-medtech-trauma-devices-market-insights-asia-pacific-supplemental-2022\/"},"modified":"2026-04-22T23:04:16","modified_gmt":"2026-04-22T23:04:16","slug":"47037286-medtech-trauma-devices-market-insights-asia-pacific-supplemental-2022","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47037286-medtech-trauma-devices-market-insights-asia-pacific-supplemental-2022\/","title":{"rendered":"Trauma Devices | Market Insights | Asia Pacific (Supplemental) | 2022"},"content":{"rendered":"<p>Compared to other major orthopedic device markets, the Asia Pacific trauma device market has been somewhat less severely impacted by the\u00a0COVID-19\u00a0pandemic given the urgent nature of many trauma cases. Nonetheless, the market has been affected by delays to nonurgent trauma cases and use of alternative treatments for less serious cases, hindering procedure volumes to some extent. Beyond the impact of the\u00a0COVID-19\u00a0pandemic, the market will expand moderately, driven by favorable demographics and rising adoption of innovative devices, although pricing pressures\u2014particularly in China, where the regional implementation of volume-based procurement for trauma devices is resulting in\u00a0ASP\u00a0declines\u2014will hinder the pace of market revenue growth.<\/p>\n<p>This Medtech 360 Report provides high-level market metrics for trauma devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 11-year period.<\/p>\n","protected":false},"template":"","class_list":["post-385979","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-trauma-devices","medtech-geography-asia-pacific","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385979\/revisions"}],"predecessor-version":[{"id":387488,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385979\/revisions\/387488"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}